Login / Signup

Biotechnological production and application of the antibiotic pimaricin: biosynthesis and its regulation.

Jesús F AparicioEva G BarrealesTamara D PayeroCláudia M VicenteAntonio de PedroJavier Santos-Aberturas
Published in: Applied microbiology and biotechnology (2015)
Pimaricin (natamycin) is a small polyene macrolide antibiotic used worldwide. This efficient antimycotic and antiprotozoal agent, produced by several soil bacterial species of the genus Streptomyces, has found application in human therapy, in the food and beverage industries and as pesticide. It displays a broad spectrum of activity, targeting ergosterol but bearing a particular mode of action different to other polyene macrolides. The biosynthesis of this only antifungal agent with a GRAS status has been thoroughly studied, which has permitted the manipulation of producers to engineer the biosynthetic gene clusters in order to generate several analogues. Regulation of its production has been largely unveiled, constituting a model for other polyenes and setting the leads for optimizing the production of these valuable compounds. This review describes and discusses the molecular genetics, uses, mode of action, analogue generation, regulation and strategies for increasing pimaricin production yields.
Keyphrases
  • endothelial cells
  • risk assessment
  • stem cells
  • dna methylation
  • gene expression
  • candida albicans
  • genome wide
  • copy number
  • cancer therapy
  • human health
  • cell wall
  • climate change
  • bone marrow